Table 2.
Tumour stage distribution for patients diagnosed via a primary care route shown for seven cancer types and total
| Before | During | After | P-valuea | CPP-referred | Non-CPP-referred | P-valueb | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
||||||||
| n | % | n | % | n | % | n | % | n | % | |||
| Colorectal cancer (n= 1985) | ||||||||||||
| Local | 86 | 30.4 | 340 | 29.0 | 201 | 32.0 | 71 | 31.7 | 130 | 32.1 | ||
| Regional | 67 | 23.7 | 279 | 23.8 | 176 | 28.0 | 67 | 29.9 | 109 | 26.9 | ||
| Distant | 63 | 22.3 | 245 | 29.4 | 166 | 26.4 | 0.874c | 62 | 27.7 | 104 | 25.7 | 0.847c |
| Unknown | 60 | 21.2 | 202 | 17.2 | 82 | 13.0 | 23 | 10.3 | 59 | 14.6 | ||
| Missing | 7 | 2.5 | 7 | 0.6 | 4 | 0.6 | 0.003d | 1 | 0.4 | 3 | 0.7 | 0.569d |
|
| ||||||||||||
| Lung cancer (n= 1799) | ||||||||||||
| Local | 51 | 18.2 | 184 | 18.1 | 68 | 13.6 | 27 | 13.4 | 41 | 13.7 | ||
| Regional | 53 | 18.9 | 167 | 16.4 | 97 | 19.4 | 41 | 20.3 | 56 | 18.7 | ||
| Distant | 149 | 53.2 | 630 | 61.9 | 322 | 64.3 | 0.055c | 132 | 65.3 | 190 | 63.5 | 0.946c |
| Unknown | 23 | 8.2 | 36 | 3.5 | 14 | 2.8 | 2 | 1.0 | 12 | 4.0 | ||
| Missing | 4 | 1.4 | 1 | 0.1 | 0 | 0.0 | <0.001d | 0 | 0.0 | 0 | 0.0 | 0.244d |
|
| ||||||||||||
| Malignant melanoma (n= 764) | ||||||||||||
| Local | 84 | 67.2 | 277 | 68.7 | 175 | 74.2 | 60 | 73.2 | 115 | 74.7 | ||
| Regional | 10 | 8.0 | 39 | 9.7 | 21 | 8.9 | 8 | 9.8 | 13 | 8.4 | ||
| Distant | 9 | 7.2 | 15 | 3.7 | 7 | 3.0 | 0.319c | 3 | 3.7 | 4 | 2.6 | 0.853c |
| Unknown | 18 | 14.4 | 65 | 16.1 | 33 | 14.0 | 11 | 13.4 | 22 | 14.3 | ||
| Missing | 4 | 3.2 | 7 | 1.7 | 0 | 0.0 | 0.159d | 0 | 0.0 | 0 | 0.0 | 0.950d |
|
| ||||||||||||
| Head and neck cancer (n= 514) | ||||||||||||
| Local | 25 | 33.8 | 96 | 36.9 | 71 | 39.4 | 16 | 41.0 | 55 | 39.0 | ||
| Regional | 38 | 51.4 | 130 | 50.0 | 65 | 36.1 | 18 | 46.2 | 47 | 33.3 | ||
| Distant | 2 | 2.7 | 11 | 4.2 | 6 | 3.3 | 0.347c | 1 | 2.6 | 5 | 3.5 | 0.704c |
| Unknown | 2 | 2.7 | 18 | 6.9 | 37 | 20.6 | 4 | 10.3 | 33 | 23.4 | ||
| Missing | 7 | 9.5 | 5 | 1.9 | 1 | 0.6 | <0.001d | 0 | 0.0 | 1 | 0.7 | 0.360d |
|
| ||||||||||||
| Upper gastrointestinal cancer (n= 1091) | ||||||||||||
| Local | 32 | 17.3 | 81 | 14.2 | 52 | 15.5 | 13 | 15.5 | 39 | 15.5 | ||
| Regional | 32 | 17.3 | 124 | 21.8 | 63 | 18.8 | 19 | 22.6 | 44 | 17.5 | ||
| Distant | 70 | 37.8 | 248 | 43.5 | 147 | 43.8 | 0.536c | 35 | 41.7 | 112 | 44.4 | 0.623c |
| Unknown | 43 | 23.2 | 108 | 18.9 | 72 | 21.4 | 17 | 20.2 | 55 | 21.8 | ||
| Missing | 8 | 4.3 | 9 | 1.6 | 2 | 0.6 | 0.057d | 0 | 0.0 | 2 | 0.8 | 0.782d |
|
| ||||||||||||
| Gynaecological cancer (n= 875) | ||||||||||||
| Local | 95 | 67.4 | 308 | 63.6 | 165 | 66.0 | 38 | 59.4 | 127 | 68.3 | ||
| Regional | 17 | 12.1 | 48 | 9.9 | 24 | 9.6 | 10 | 15.6 | 14 | 7.5 | ||
| Distant | 15 | 10.6 | 61 | 12.6 | 38 | 15.2 | 0.742c | 11 | 17.2 | 27 | 14.5 | 0.136c |
| Unknown | 8 | 5.7 | 59 | 12.2 | 22 | 8.8 | 4 | 6.3 | 18 | 9.7 | ||
| Missing | 6 | 4.3 | 8 | 1.7 | 1 | 0.4 | 0.049d | 1 | 1.6 | 0 | 0.0 | 0.108d |
|
| ||||||||||||
| Urinary system cancer (n= 697) | ||||||||||||
| Local | 79 | 69.3 | 244 | 64.4 | 136 | 66.7 | 47 | 61.0 | 89 | 70.1 | ||
| Regional | 2 | 1.8 | 20 | 5.3 | 12 | 5.9 | 6 | 7.8 | 6 | 4.7 | ||
| Distant | 22 | 19.3 | 84 | 22.2 | 33 | 16.2 | 0.241c | 13 | 16.9 | 20 | 15.7 | 0.526c |
| Unknown | 8 | 7.0 | 21 | 5.5 | 22 | 10.8 | 10 | 13.0 | 12 | 9.4 | ||
| Missing | 3 | 2.6 | 10 | 2.6 | 1 | 0.5 | 0.084d | 1 | 1.3 | 0 | 0.0 | 0.463d |
|
| ||||||||||||
| All cancers (n= 7725) | ||||||||||||
| Local | 452 | 37.6 | 1530 | 36.5 | 868 | 37.2 | 272 | 35.3 | 596 | 38.1 | ||
| Regional | 219 | 18.2 | 807 | 19.3 | 458 | 19.6 | 168 | 21.8 | 289 | 18.5 | ||
| Distant | 330 | 27.5 | 1294 | 30.9 | 719 | 30.8 | 0.494c | 257 | 33.3 | 462 | 29.5 | 0.067c |
| Unknown | 162 | 13.5 | 509 | 12.2 | 282 | 12.1 | 71 | 9.2 | 211 | 13.5 | ||
| Missing | 39 | 3.2 | 47 | 1.1 | 9 | 0.4 | <0.001d | 3 | 0.4 | 6 | 0.4 | 0.006d |
Test for differences in tumour stage distribution across time.
Test for differences in tumour stage distribution between CPP-referred and non-CPP-referred patients.
Missing and unknown stage excluded.
Missing and unknown stage included.
CPP = cancer patient pathway.